Clinical Trial Update: Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

View source ↗

Summary

A completed clinical trial in Croatia evaluated the effects of candesartan cilexetil on clinical signs and symptoms in patients with chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Heart Failure | Status: COMPLETED